UK mixed vaccine trial to tackle 4,000 variants

Published February 4, 2021 83 Views

Rumble British researchers are to explore mixing doses of the Pfizer and AstraZeneca vaccines in a world first trial aimed tackling an estimated 4,000 variants of COVID-19. Adam Reed reports.